1. Market Research
  2. > Pharmaceutical Market Trends
U.S. Pharmaceuticals Industry Analysis and Trends 2023

U.S. Pharmaceuticals Industry Analysis and Trends 2023

  • March 2019
  • 255 pages
  • ID: 5761205
  • Format: PDF
  • NAVADHI Market Research

Summary

Table of Contents

U.S. (United States) pharmaceutical market is the largest pharmaceuticals market in the world and accounted for more than 40% global pharmaceuticals sales in 2017. USA pharmaceuticals market is expected to grow in the upcoming years despite recent slowdown due to price erosion in U.S. generics pharmaceuticals market, delay in approval of complex generics by US FDA (United States Food and Drug Administration) and Government’s talks of drug price control mechanism like other major pharmaceutical markets. The reasons are simple: aging and growing population, rising income levels, and emerging medical conditions and emergence of new diseases.

The U.S. pharmaceutical industry will we worth USD 685.45 billion by 2023. The growth in this market is predicted on the basis of various factors like market drivers, current and upcoming trends, current growth pattern, and market challenges.

U.S. is expected to retain it’s leading position in the global pharmaceuticals market with market share of 43.72% in 2023 improving on it’s market share compared to 2017.

This growth is fuelled by the growing and ageing population in U.S. More than 15% of U.S. population is above 65 years of age and this number is expected to rise by 2023. Apart from ageing and rising population the improvements in purchasing power and access to quality healthcare and pharmaceuticals to poor and middle-class families worldwide also is driving the growth of U.S. pharma industry. The income level of average American is expected to rise by 3.21% CAGR by 2023, due to rising employment levels and stable economic conditions. Another aspect which is leading this growth is rising focus of pharmaceuticals companies to tap the rare and speciality diseases. Innovations in advanced biologics, nucleic acid therapeutics, cell therapies and bioelectronics & implantables has attracted investments in the industry by even non-pharma companies like Facebook, Qualcomm etc. which is also driving the U.S. pharmaceuticals industry growth.

On the other hand, United States government’s plan to implement of cost control policies along with tightening of rules by government like delay in approval of complex generics and price erosion in U.S. generics pharmaceuticals market are expected to impact the growth prospect of the U.S. pharmaceuticals industry. Pharmaceuticals companies are forced to reduce their research and development (R&D) spending due to slowdown of growth in last few years which is also expected to hamper growth of the U.S. pharma market as new drugs revenue form large part of pharma firm’s revenue due to exclusivity of the drug.

The analyst has provided detailed company profiles including their position in U.S pharmaceuticals market value chain, financial performance analysis, product wise business strategy, competitive landscape and SWOT analysis for top 10 companies in U.S. pharmaceuticals market by their pharmaceuticals revenue namely: Pfizer Inc., Johnson & Johnson, Roche Holding AG, AbbVie Inc., Amgen, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., Sanofi S.A and Bristol-Myers Squib
Scope of the U.S. Pharmaceuticals Industry Analysis and Trends 2023 Report
This report provides detailed information about United States pharmaceuticals market including future market forecasts up to 2023.
This report identifies the need for focusing on U.S. pharmaceuticals market
The report identifies the growth drivers and inhibitors for U.S. pharmaceuticals market.
The report identifies various risks associated with U.S. pharmaceuticals market.
This report has detailed profiles of top 10 companies in U.S. pharmaceuticals market by their pharmaceutical revenue covering their position in pharmaceuticals value chain, business strategy, financial performance, future forecasts and SWOT analysis.
This report provides competitive landscape among top 10 pharmaceutical companies in U.S. market.
This report provides Porter’s Five Forces analysis for U.S. pharmaceuticals market.
This report provides SWOT (strengths, weakness, opportunities and threats) analysis for U.S. pharmaceuticals market.
This report provides information about current and future trends for U.S. pharmaceuticals market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Emerging Pharmaceuticals Markets in China

  • $ 4000
  • June 2021
  • 238 pages

China’s demand for Emerging Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high ...

  • China
  • United States
  • Pharmaceutical
  • Industry analysis
  • Pharmaceutical Production
  • Industrial Production

ref:plp2019

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on